Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

48.03 +0.49 (+1.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist

Other Filings

Form SC 13G/A
Source: SEC/Edgar
February 12, 2018
Form SC 13G/A
Source: SEC/Edgar
February 08, 2018
Form SC 13G/A
Source: SEC/Edgar
February 05, 2018
Form SC 13G/A
Source: SEC/Edgar
February 04, 2018
Form SC 13G/A
Source: SEC/Edgar
January 24, 2018
Form 8-K
Source: SEC/Edgar
January 11, 2018
Form 8-K
Source: SEC/Edgar
January 09, 2018
Form 8-K
Source: SEC/Edgar
September 28, 2017
Form 8-K
Source: SEC/Edgar
August 07, 2017
Form SC 13D/A
Source: SEC/Edgar
July 25, 2017
Form 8-K
Source: SEC/Edgar
July 04, 2017
Form DEFA14A
Source: SEC/Edgar
March 23, 2017
Form DEF 14A
Source: SEC/Edgar
March 23, 2017
Form SC 13G/A
Source: SEC/Edgar
February 13, 2017
Form SC 13G
Source: SEC/Edgar
February 13, 2017
Form SC 13G/A
Source: SEC/Edgar
February 12, 2017
Form SC 13G
Source: SEC/Edgar
February 05, 2017
Form 8-K
Source: SEC/Edgar
January 09, 2017
Form 8-K
Source: SEC/Edgar
January 08, 2017
Form 8-K
Source: SEC/Edgar
January 04, 2017
Form 8-K
Source: SEC/Edgar
December 18, 2016
Form 8-K
Source: SEC/Edgar
November 06, 2016
Form 8-K
Source: SEC/Edgar
August 31, 2016
Form 8-K
Source: SEC/Edgar
August 08, 2016
Form CT ORDER
Source: SEC/Edgar
June 13, 2016
Form 8-K
Source: SEC/Edgar
June 07, 2016
Form SC 13D/A
Source: SEC/Edgar
June 01, 2016
Form 8-K
Source: SEC/Edgar
May 08, 2016
Form S-8
Source: SEC/Edgar
May 08, 2016
Form 8-K
Source: SEC/Edgar
May 05, 2016
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.